Celldex intends to grow the Company through a balanced combination of (a) internal development of product candidates, (b) continued in-licensing of synergistic technologies and adjuvant products, and (c) strategic mergers and acquisitions.
Celldex has a highly experienced management team to implement its near- and long-term objectives of advancing multiple pre-clinical and clinical development programs through development. With such clinical data in hand, we plan to identify optimal co-development and commercialization partners to market our products most effectively. Celldex intends to enter into strategic partnerships with global biopharmaceutical companies to enhance our ability to get our products to the appropriate patient populations.
Precision Targeted Immunotherapy